Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: A multicenter study

Objectives The present multicenter study compared the usefulness of the solid tumor size with that of the whole tumor size on preoperative high-resolution computed tomography for predicting pathologic high-grade malignancy (positive lymphatic, vascular, or pleural invasion) and the prognosis of clin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of thoracic and cardiovascular surgery 2012-03, Vol.143 (3), p.607-612
Hauptverfasser: Tsutani, Yasuhiro, MD, PhD, Miyata, Yoshihiro, MD, PhD, Nakayama, Haruhiko, MD, PhD, Okumura, Sakae, MD, PhD, Adachi, Shuji, MD, PhD, Yoshimura, Masahiro, MD, PhD, Okada, Morihito, MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 612
container_issue 3
container_start_page 607
container_title The Journal of thoracic and cardiovascular surgery
container_volume 143
creator Tsutani, Yasuhiro, MD, PhD
Miyata, Yoshihiro, MD, PhD
Nakayama, Haruhiko, MD, PhD
Okumura, Sakae, MD, PhD
Adachi, Shuji, MD, PhD
Yoshimura, Masahiro, MD, PhD
Okada, Morihito, MD, PhD
description Objectives The present multicenter study compared the usefulness of the solid tumor size with that of the whole tumor size on preoperative high-resolution computed tomography for predicting pathologic high-grade malignancy (positive lymphatic, vascular, or pleural invasion) and the prognosis of clinical stage IA lung adenocarcinoma. Methods We performed high-resolution computed tomography and F-18 fluorodeoxyglucose-positron emission tomography/computed tomography before curative surgical resection in 502 patients with clinical stage IA lung adenocarcinoma. The revised maximum standardized uptake values on F-18 fluorodeoxyglucose-positron emission tomography/computed tomography were used to correct interinstitutional discrepancies. The whole and solid tumor sizes on high-resolution computed tomography were then analyzed in relation to surgical results. Results The mean whole and solid tumor size was 1.97 ± 0.59 cm and 1.20 ± 0.88 cm, respectively. The receiver operating characteristics area under the curve for the whole and solid tumor sizes used to identify high-grade malignancy were 0.590 and 0.829, respectively. Multiple logistic regression analyses demonstrated solid tumor size ( P  
doi_str_mv 10.1016/j.jtcvs.2011.10.037
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_922497480</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022522311011561</els_id><sourcerecordid>922497480</sourcerecordid><originalsourceid>FETCH-LOGICAL-c554t-1a2703e3ea8d52b28e2cdd5971a58968446339bf6242acbdd23b298b10fa17573</originalsourceid><addsrcrecordid>eNqFktuKFDEQhhtR3HH1CQTJjXjVY5I-CwrD4mFhQUEF70I6qe7J2N3pzWFkfFFfx-qZWQVvvAoJX_31p_5KkqeMrhll5cvdehfU3q85ZQxf1jSr7iUrRpsqLevi2_1kRSnnacF5dpE88n5HKa0oax4mF5wzmpdVvUp-fXK2n6wPRhFv-sl0RslJAbEdid5MPfF2MJrswfnoyY-tHYCEOFqH-E_EJrI1_TZ1gFwMBu_KjnMMoEmwo-2dnLcH0iE_O9BGhUVzlgGFbI9NRzlgWzkFgqg-9j3Ke2JQajAT-hmID7IHcr0hQ8Ry5CarpFNmsqN8RTZkjAP-AKYA6CtEfXicPOjk4OHJ-bxMvr57--XqQ3rz8f311eYmVUWRh5RJXtEMMpC1LnjLa-BK66KpmCzqpqzzvMyypu1KnnOpWq151vKmbhntJKuKKrtMXpx0Z2dvI_ggRuMVDIOcwEYvGs7zpsprimR2IpWz3jvoxOzMKN1BMCqWQMVOHAMVS6DLIwaKVc_O-rEdQf-puUsQgednQHqcVOcwPeP_ckXJaMkYcq9PHOA09gac8MoAJq2NAxWEtuY_Rt78U38Xznc4gN_Z6CYctGDCc0HF52X3ltVjqMjQRPYbjBnayw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>922497480</pqid></control><display><type>article</type><title>Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: A multicenter study</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Tsutani, Yasuhiro, MD, PhD ; Miyata, Yoshihiro, MD, PhD ; Nakayama, Haruhiko, MD, PhD ; Okumura, Sakae, MD, PhD ; Adachi, Shuji, MD, PhD ; Yoshimura, Masahiro, MD, PhD ; Okada, Morihito, MD, PhD</creator><creatorcontrib>Tsutani, Yasuhiro, MD, PhD ; Miyata, Yoshihiro, MD, PhD ; Nakayama, Haruhiko, MD, PhD ; Okumura, Sakae, MD, PhD ; Adachi, Shuji, MD, PhD ; Yoshimura, Masahiro, MD, PhD ; Okada, Morihito, MD, PhD</creatorcontrib><description>Objectives The present multicenter study compared the usefulness of the solid tumor size with that of the whole tumor size on preoperative high-resolution computed tomography for predicting pathologic high-grade malignancy (positive lymphatic, vascular, or pleural invasion) and the prognosis of clinical stage IA lung adenocarcinoma. Methods We performed high-resolution computed tomography and F-18 fluorodeoxyglucose-positron emission tomography/computed tomography before curative surgical resection in 502 patients with clinical stage IA lung adenocarcinoma. The revised maximum standardized uptake values on F-18 fluorodeoxyglucose-positron emission tomography/computed tomography were used to correct interinstitutional discrepancies. The whole and solid tumor sizes on high-resolution computed tomography were then analyzed in relation to surgical results. Results The mean whole and solid tumor size was 1.97 ± 0.59 cm and 1.20 ± 0.88 cm, respectively. The receiver operating characteristics area under the curve for the whole and solid tumor sizes used to identify high-grade malignancy were 0.590 and 0.829, respectively. Multiple logistic regression analyses demonstrated solid tumor size ( P  &lt; .001) and maximum standardized uptake values of the tumor ( P  &lt; .001) as independent variables for the prediction of high-grade malignancy. Multivariate Cox analysis of disease-free survival demonstrated the former (hazard ratio, 2.30; 95% confidence interval, 1.46-3.63; P  &lt; .001) and latter (hazard ratio, 1.08; 95% confidence interval, 1.00-1.17; P  = .05) as independent prognostic factors. Conclusions The solid tumor size on high-resolution computed tomography and maximum standardized uptake values on positron emission tomography/computed tomography have greater predictive value for high-grade malignancy and prognosis in clinical stage IA lung adenocarcinoma than that of whole tumor size.</description><identifier>ISSN: 0022-5223</identifier><identifier>EISSN: 1097-685X</identifier><identifier>DOI: 10.1016/j.jtcvs.2011.10.037</identifier><identifier>PMID: 22104678</identifier><identifier>CODEN: JTCSAQ</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Adenocarcinoma - diagnostic imaging ; Adenocarcinoma - mortality ; Adenocarcinoma - pathology ; Adenocarcinoma of Lung ; Aged ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Cardiology. Vascular system ; Cardiothoracic Surgery ; Disease-Free Survival ; Female ; Fluorodeoxyglucose F18 ; Humans ; Japan ; Kaplan-Meier Estimate ; Logistic Models ; Lung Neoplasms - diagnostic imaging ; Lung Neoplasms - mortality ; Lung Neoplasms - pathology ; Male ; Medical sciences ; Middle Aged ; Multimodal Imaging ; Multiple tumors. Solid tumors. Tumors in childhood (general aspects) ; Neoplasm Grading ; Neoplasm Staging ; Pneumology ; Positron-Emission Tomography ; Predictive Value of Tests ; Prognosis ; Proportional Hazards Models ; Radiopharmaceuticals ; Risk Assessment ; Risk Factors ; Survival Rate ; Time Factors ; Tomography, X-Ray Computed ; Tumor Burden ; Tumors ; Tumors of the respiratory system and mediastinum</subject><ispartof>The Journal of thoracic and cardiovascular surgery, 2012-03, Vol.143 (3), p.607-612</ispartof><rights>The American Association for Thoracic Surgery</rights><rights>2012 The American Association for Thoracic Surgery</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c554t-1a2703e3ea8d52b28e2cdd5971a58968446339bf6242acbdd23b298b10fa17573</citedby><cites>FETCH-LOGICAL-c554t-1a2703e3ea8d52b28e2cdd5971a58968446339bf6242acbdd23b298b10fa17573</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jtcvs.2011.10.037$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25610611$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22104678$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tsutani, Yasuhiro, MD, PhD</creatorcontrib><creatorcontrib>Miyata, Yoshihiro, MD, PhD</creatorcontrib><creatorcontrib>Nakayama, Haruhiko, MD, PhD</creatorcontrib><creatorcontrib>Okumura, Sakae, MD, PhD</creatorcontrib><creatorcontrib>Adachi, Shuji, MD, PhD</creatorcontrib><creatorcontrib>Yoshimura, Masahiro, MD, PhD</creatorcontrib><creatorcontrib>Okada, Morihito, MD, PhD</creatorcontrib><title>Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: A multicenter study</title><title>The Journal of thoracic and cardiovascular surgery</title><addtitle>J Thorac Cardiovasc Surg</addtitle><description>Objectives The present multicenter study compared the usefulness of the solid tumor size with that of the whole tumor size on preoperative high-resolution computed tomography for predicting pathologic high-grade malignancy (positive lymphatic, vascular, or pleural invasion) and the prognosis of clinical stage IA lung adenocarcinoma. Methods We performed high-resolution computed tomography and F-18 fluorodeoxyglucose-positron emission tomography/computed tomography before curative surgical resection in 502 patients with clinical stage IA lung adenocarcinoma. The revised maximum standardized uptake values on F-18 fluorodeoxyglucose-positron emission tomography/computed tomography were used to correct interinstitutional discrepancies. The whole and solid tumor sizes on high-resolution computed tomography were then analyzed in relation to surgical results. Results The mean whole and solid tumor size was 1.97 ± 0.59 cm and 1.20 ± 0.88 cm, respectively. The receiver operating characteristics area under the curve for the whole and solid tumor sizes used to identify high-grade malignancy were 0.590 and 0.829, respectively. Multiple logistic regression analyses demonstrated solid tumor size ( P  &lt; .001) and maximum standardized uptake values of the tumor ( P  &lt; .001) as independent variables for the prediction of high-grade malignancy. Multivariate Cox analysis of disease-free survival demonstrated the former (hazard ratio, 2.30; 95% confidence interval, 1.46-3.63; P  &lt; .001) and latter (hazard ratio, 1.08; 95% confidence interval, 1.00-1.17; P  = .05) as independent prognostic factors. Conclusions The solid tumor size on high-resolution computed tomography and maximum standardized uptake values on positron emission tomography/computed tomography have greater predictive value for high-grade malignancy and prognosis in clinical stage IA lung adenocarcinoma than that of whole tumor size.</description><subject>Adenocarcinoma - diagnostic imaging</subject><subject>Adenocarcinoma - mortality</subject><subject>Adenocarcinoma - pathology</subject><subject>Adenocarcinoma of Lung</subject><subject>Aged</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Cardiothoracic Surgery</subject><subject>Disease-Free Survival</subject><subject>Female</subject><subject>Fluorodeoxyglucose F18</subject><subject>Humans</subject><subject>Japan</subject><subject>Kaplan-Meier Estimate</subject><subject>Logistic Models</subject><subject>Lung Neoplasms - diagnostic imaging</subject><subject>Lung Neoplasms - mortality</subject><subject>Lung Neoplasms - pathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Multimodal Imaging</subject><subject>Multiple tumors. Solid tumors. Tumors in childhood (general aspects)</subject><subject>Neoplasm Grading</subject><subject>Neoplasm Staging</subject><subject>Pneumology</subject><subject>Positron-Emission Tomography</subject><subject>Predictive Value of Tests</subject><subject>Prognosis</subject><subject>Proportional Hazards Models</subject><subject>Radiopharmaceuticals</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>Survival Rate</subject><subject>Time Factors</subject><subject>Tomography, X-Ray Computed</subject><subject>Tumor Burden</subject><subject>Tumors</subject><subject>Tumors of the respiratory system and mediastinum</subject><issn>0022-5223</issn><issn>1097-685X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFktuKFDEQhhtR3HH1CQTJjXjVY5I-CwrD4mFhQUEF70I6qe7J2N3pzWFkfFFfx-qZWQVvvAoJX_31p_5KkqeMrhll5cvdehfU3q85ZQxf1jSr7iUrRpsqLevi2_1kRSnnacF5dpE88n5HKa0oax4mF5wzmpdVvUp-fXK2n6wPRhFv-sl0RslJAbEdid5MPfF2MJrswfnoyY-tHYCEOFqH-E_EJrI1_TZ1gFwMBu_KjnMMoEmwo-2dnLcH0iE_O9BGhUVzlgGFbI9NRzlgWzkFgqg-9j3Ke2JQajAT-hmID7IHcr0hQ8Ry5CarpFNmsqN8RTZkjAP-AKYA6CtEfXicPOjk4OHJ-bxMvr57--XqQ3rz8f311eYmVUWRh5RJXtEMMpC1LnjLa-BK66KpmCzqpqzzvMyypu1KnnOpWq151vKmbhntJKuKKrtMXpx0Z2dvI_ggRuMVDIOcwEYvGs7zpsprimR2IpWz3jvoxOzMKN1BMCqWQMVOHAMVS6DLIwaKVc_O-rEdQf-puUsQgednQHqcVOcwPeP_ckXJaMkYcq9PHOA09gac8MoAJq2NAxWEtuY_Rt78U38Xznc4gN_Z6CYctGDCc0HF52X3ltVjqMjQRPYbjBnayw</recordid><startdate>20120301</startdate><enddate>20120301</enddate><creator>Tsutani, Yasuhiro, MD, PhD</creator><creator>Miyata, Yoshihiro, MD, PhD</creator><creator>Nakayama, Haruhiko, MD, PhD</creator><creator>Okumura, Sakae, MD, PhD</creator><creator>Adachi, Shuji, MD, PhD</creator><creator>Yoshimura, Masahiro, MD, PhD</creator><creator>Okada, Morihito, MD, PhD</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120301</creationdate><title>Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: A multicenter study</title><author>Tsutani, Yasuhiro, MD, PhD ; Miyata, Yoshihiro, MD, PhD ; Nakayama, Haruhiko, MD, PhD ; Okumura, Sakae, MD, PhD ; Adachi, Shuji, MD, PhD ; Yoshimura, Masahiro, MD, PhD ; Okada, Morihito, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c554t-1a2703e3ea8d52b28e2cdd5971a58968446339bf6242acbdd23b298b10fa17573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adenocarcinoma - diagnostic imaging</topic><topic>Adenocarcinoma - mortality</topic><topic>Adenocarcinoma - pathology</topic><topic>Adenocarcinoma of Lung</topic><topic>Aged</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Cardiothoracic Surgery</topic><topic>Disease-Free Survival</topic><topic>Female</topic><topic>Fluorodeoxyglucose F18</topic><topic>Humans</topic><topic>Japan</topic><topic>Kaplan-Meier Estimate</topic><topic>Logistic Models</topic><topic>Lung Neoplasms - diagnostic imaging</topic><topic>Lung Neoplasms - mortality</topic><topic>Lung Neoplasms - pathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Multimodal Imaging</topic><topic>Multiple tumors. Solid tumors. Tumors in childhood (general aspects)</topic><topic>Neoplasm Grading</topic><topic>Neoplasm Staging</topic><topic>Pneumology</topic><topic>Positron-Emission Tomography</topic><topic>Predictive Value of Tests</topic><topic>Prognosis</topic><topic>Proportional Hazards Models</topic><topic>Radiopharmaceuticals</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>Survival Rate</topic><topic>Time Factors</topic><topic>Tomography, X-Ray Computed</topic><topic>Tumor Burden</topic><topic>Tumors</topic><topic>Tumors of the respiratory system and mediastinum</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tsutani, Yasuhiro, MD, PhD</creatorcontrib><creatorcontrib>Miyata, Yoshihiro, MD, PhD</creatorcontrib><creatorcontrib>Nakayama, Haruhiko, MD, PhD</creatorcontrib><creatorcontrib>Okumura, Sakae, MD, PhD</creatorcontrib><creatorcontrib>Adachi, Shuji, MD, PhD</creatorcontrib><creatorcontrib>Yoshimura, Masahiro, MD, PhD</creatorcontrib><creatorcontrib>Okada, Morihito, MD, PhD</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of thoracic and cardiovascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tsutani, Yasuhiro, MD, PhD</au><au>Miyata, Yoshihiro, MD, PhD</au><au>Nakayama, Haruhiko, MD, PhD</au><au>Okumura, Sakae, MD, PhD</au><au>Adachi, Shuji, MD, PhD</au><au>Yoshimura, Masahiro, MD, PhD</au><au>Okada, Morihito, MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: A multicenter study</atitle><jtitle>The Journal of thoracic and cardiovascular surgery</jtitle><addtitle>J Thorac Cardiovasc Surg</addtitle><date>2012-03-01</date><risdate>2012</risdate><volume>143</volume><issue>3</issue><spage>607</spage><epage>612</epage><pages>607-612</pages><issn>0022-5223</issn><eissn>1097-685X</eissn><coden>JTCSAQ</coden><abstract>Objectives The present multicenter study compared the usefulness of the solid tumor size with that of the whole tumor size on preoperative high-resolution computed tomography for predicting pathologic high-grade malignancy (positive lymphatic, vascular, or pleural invasion) and the prognosis of clinical stage IA lung adenocarcinoma. Methods We performed high-resolution computed tomography and F-18 fluorodeoxyglucose-positron emission tomography/computed tomography before curative surgical resection in 502 patients with clinical stage IA lung adenocarcinoma. The revised maximum standardized uptake values on F-18 fluorodeoxyglucose-positron emission tomography/computed tomography were used to correct interinstitutional discrepancies. The whole and solid tumor sizes on high-resolution computed tomography were then analyzed in relation to surgical results. Results The mean whole and solid tumor size was 1.97 ± 0.59 cm and 1.20 ± 0.88 cm, respectively. The receiver operating characteristics area under the curve for the whole and solid tumor sizes used to identify high-grade malignancy were 0.590 and 0.829, respectively. Multiple logistic regression analyses demonstrated solid tumor size ( P  &lt; .001) and maximum standardized uptake values of the tumor ( P  &lt; .001) as independent variables for the prediction of high-grade malignancy. Multivariate Cox analysis of disease-free survival demonstrated the former (hazard ratio, 2.30; 95% confidence interval, 1.46-3.63; P  &lt; .001) and latter (hazard ratio, 1.08; 95% confidence interval, 1.00-1.17; P  = .05) as independent prognostic factors. Conclusions The solid tumor size on high-resolution computed tomography and maximum standardized uptake values on positron emission tomography/computed tomography have greater predictive value for high-grade malignancy and prognosis in clinical stage IA lung adenocarcinoma than that of whole tumor size.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>22104678</pmid><doi>10.1016/j.jtcvs.2011.10.037</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-5223
ispartof The Journal of thoracic and cardiovascular surgery, 2012-03, Vol.143 (3), p.607-612
issn 0022-5223
1097-685X
language eng
recordid cdi_proquest_miscellaneous_922497480
source MEDLINE; Access via ScienceDirect (Elsevier); EZB-FREE-00999 freely available EZB journals
subjects Adenocarcinoma - diagnostic imaging
Adenocarcinoma - mortality
Adenocarcinoma - pathology
Adenocarcinoma of Lung
Aged
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Cardiology. Vascular system
Cardiothoracic Surgery
Disease-Free Survival
Female
Fluorodeoxyglucose F18
Humans
Japan
Kaplan-Meier Estimate
Logistic Models
Lung Neoplasms - diagnostic imaging
Lung Neoplasms - mortality
Lung Neoplasms - pathology
Male
Medical sciences
Middle Aged
Multimodal Imaging
Multiple tumors. Solid tumors. Tumors in childhood (general aspects)
Neoplasm Grading
Neoplasm Staging
Pneumology
Positron-Emission Tomography
Predictive Value of Tests
Prognosis
Proportional Hazards Models
Radiopharmaceuticals
Risk Assessment
Risk Factors
Survival Rate
Time Factors
Tomography, X-Ray Computed
Tumor Burden
Tumors
Tumors of the respiratory system and mediastinum
title Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: A multicenter study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T18%3A01%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20significance%20of%20using%20solid%20versus%20whole%20tumor%20size%20on%20high-resolution%20computed%20tomography%20for%20predicting%20pathologic%20malignant%20grade%20of%20tumors%20in%20clinical%20stage%20IA%20lung%20adenocarcinoma:%20A%20multicenter%20study&rft.jtitle=The%20Journal%20of%20thoracic%20and%20cardiovascular%20surgery&rft.au=Tsutani,%20Yasuhiro,%20MD,%20PhD&rft.date=2012-03-01&rft.volume=143&rft.issue=3&rft.spage=607&rft.epage=612&rft.pages=607-612&rft.issn=0022-5223&rft.eissn=1097-685X&rft.coden=JTCSAQ&rft_id=info:doi/10.1016/j.jtcvs.2011.10.037&rft_dat=%3Cproquest_cross%3E922497480%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=922497480&rft_id=info:pmid/22104678&rft_els_id=S0022522311011561&rfr_iscdi=true